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mmature dendritic cells (DCs) sample their environment
for antigens and after stimulation present peptide associ-
ated  with major histocompatibility complex class II
 
(
 
MHC II) to naive T cells. We have studied the intracellular
trafﬁcking of MHC II in cultured DCs. In immature cells,
 
the majority of MHC II was stored intracellularly at the
 
internal vesicles of multivesicular bodies (MVBs). In contrast,
DM, an accessory molecule required for peptide load-
ing, was located predominantly at the limiting membrane
of MVBs. After stimulation, the internal vesicles carrying
I
 
MHC II were transferred to the limiting membrane of the
 
MVB, bringing MHC II and DM to the same membrane
domain. Concomitantly, the MVBs transformed into long
tubular organelles that extended into the periphery of the
cells. Vesicles that were formed at the tips of these tubules
nonselectively incorporated MHC II and DM and presumably
mediated transport to the plasma membrane. We propose that
in maturing DCs, the reorganization of MVBs is fundamental
for the timing of MHC II antigen loading and transport to the
plasma membrane.
 
Introduction
 
Dendritic cells (DCs)* play a crucial role in the immune
system, since they uniquely initiate primary T cell responses
(Hart, 1997; Banchereau and Steinman, 1998). Antigen
loading of major histocompatibility complex class II
(MHC II) molecules in DCs is a tightly regulated process
associated with maturation of these cells and induced by
proinflammatory stimuli (Mellman et al., 1998). Imma-
ture DCs reside in peripheral tissues where they sample
their environment for antigens (for example, pathogens;
Sallusto et al., 1995) by receptor-mediated endocytosis,
macropinocytosis, and phagocytosis (for review see Reg-
nault et al., 1999). Upon receiving a maturation stimulus,
DCs are transformed into potent antigen-presenting cells
capable of activating naive T lymphocytes. In addition to
the coordinate expression of chemokines and chemokine
receptors (Dieu et al., 1998; Tang and Cyster, 1999) and
their migration to the draining lymph organs, DC matura-
tion is characterized by increased surface expression of
MHC I, MHC II, and multiple costimulatory molecules
(for example, CD40, CD80, and CD86) (for review see
Hart, 1997). An increase in surface expression of MHC II
is accomplished mainly by the redistribution of a presyn-
thesized pool from intracellular storage sites to the plasma
membrane (Sallusto et al., 1995; Pierre et al., 1997b;
Winzler et al., 1997). The intracellular storage sites of
MHC II in immature DCs are similar to those in other
MHC II–expressing cells and have the characteristics of late
endocytic multivesicular bodies (MVBs) or lysosomes.
Collectively, these compartments are referred to as MHC
II–enriched compartments (MIICs) (Peters et al., 1991;
Kleijmeer et al., 1997; Geuze, 1998). In MIICs, MHC II
molecules are loaded potentially with peptides that are derived
from endocytosed proteins for presentation to helper T
lymphocytes (for review see Watts, 1997; Geuze, 1998;
Mellman et al., 1998).
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Transport of newly synthesized MHC II to the endocytic
tract requires its association with invariant chain (Ii) (for re-
view see Cresswell, 1996). In MIICs, Ii is processed pro-
teolytically to a polypeptide, the CLIP fragment, which re-
mains associated with the peptide-binding groove of MHC
II (Blum and Cresswell, 1988; Roche and Cresswell, 1991;
Germain, 1994). Upon DC stimulation, the CLIP fragment
can be replaced by antigen-derived peptide present in the
MIIC with the aid of the accessory molecules HLA-DM
(H2-M or H2-DM in mice, further called DM) and HLA-
DO (H2-O; Kropshofer et al., 1999; for review see Alfonso
and Karlsson, 2000). Although the regulation of MHC II
peptide loading in DCs has been studied extensively (Pierre
and Mellman, 1998; Inaba et al., 2000; Pierre et al., 2000;
Turley et al., 2000), many questions remain. For example,
the mechanism of retention of MHC II by MIICs in imma-
ture DCs and the process by which MHC II is transferred
from their peptide-loading site to the plasma membrane
have not been solved (Pond and Watts, 1999; Ramm et al.,
2000; Turley et al., 2000).
The most prominent type of MIIC in immature DCs is the
MVB (Nijman et al., 1995; Thery et al., 1999). MVBs are
present ubiquitously in all eukaryotic cells. They are 300–500
nm vacuoles with numerous 50–80 nm membrane vesicles in
their lumen. Although MVBs have been described as such for
the first time in 1959 (Sotelo and Porter, 1959), others had re-
ported already similar structures in 1955 (Bernard et al., 1955;
Palade, 1955; Palay and Palade, 1955; Yamada, 1955). To
date, the functionality of this remarkable architecture has re-
mained elusive. The internal vesicles are formed by invagina-
tions of the limiting membrane budding into the lumen of the
MVB (Hirsch et al., 1968; Pan et al., 1985) by a process that
requires PI-3 and PI-5 kinase activities (Odorizzi et al., 1998;
Fernandez-Borja et al., 1999). MVBs contain many acid hy-
drolases, degrading a wide variety of protein and lipid sub-
strates. Thus, one fate of the internal vesicles is the degradation
of their components. A well-characterized example is the epi-
dermal growth factor receptor, which is endocytosed and accu-
mulates at the MVB’s internal membrane vesicles only after
binding of a cognate ligand (Felder et al., 1990; Renfrew and
Hubbard, 1991). A second defined role for MVBs stems from
their ability to fuse with the plasma membrane. When this oc-
curs, the internal vesicles are released into the extracellular mi-
lieu (Johnstone et al., 1987; Raposo et al., 1996). These se-
creted vesicles have been termed exosomes, and little is known
regarding their role in vivo (for review see Denzer et al., 2000).
Interestingly, fusion of the MVB with the plasma membrane
has also been proposed as a mechanism to transfer MHC II/
peptide complexes to the cell surface. However, this process
would only transfer MHC II from the MVB limiting mem-
brane (Raposo et al., 1996; Thery et al., 1999). We find that
the majority of the MHC II in MVBs is present on the inter-
nal vesicles, indicating that this fusion event would result in
inefficient delivery of MHC II to the plasma membrane. The
observation that secretion of MHC II carrying exosomes is de-
creased during DC maturation (Thery et al., 1999) also argues
that other transport mechanisms are involved in the rapid and
efficient transfer of MHC II to the cell surface of DCs. One
such mechanism may involve transport vesicles budding from
MIICs. Although clathrin coats have been identified on
 
MIICs in melanocytes, they do not recruit selectively peptide-
loaded MHC II molecules (Ramm et al., 2000). As an alterna-
tive, an intermediate compartment termed class II vesicles
(CIIVs) could be responsible for the transfer of MHC II from
the MVB to the cell surface (Turley et al., 2000).
In the present study, we show that in immature DCs the
internal vesicles of MVBs function as a storage site for MHC
II. When DCs were stimulated to mature, the MHC II car-
rying internal vesicles were transferred to the MVB limiting
membrane. Importantly, this transfer of MHC II from the
internal vesicles to the DM-containing limiting membrane
possibly facilitated MHC II antigen loading. The reorgani-
zation of membrane also resulted in a striking tubular out-
growth of MIICs. The tubular compartments were directed
towards the cell surface and formed MHC II carrying vesi-
cles at their tips. These vesicles presumably transported
MHC II to the plasma membrane. Collectively, our data in-
dicate that structural changes of MVBs in DCs are crucial
for the regulation of antigen presentation.
 
Results
 
MHC II expression at the cell surface is upregulated 
during DC maturation
 
To study transport of MHC II molecules from their intracel-
lular storage site, the late endosomal/lysosomal MIICs, to the
cell surface we used D1 cells. D1 is a well-characterized
growth factor–dependent long term culture of isolated splenic
mouse DCs that behaves identical to freshly isolated DCs
(Sallusto et al., 1995; Pierre et al., 1997a; Winzler et al.,
1997). Stimulation of D1 cells with living bacteria or bacterial
compounds like lipopolysaccharide (LPS) results in increased
surface expression of MHC II and costimulatory molecules
(Rescigno et al., 1997, 1998; Winzler et al., 1997) and a con-
comitant depletion of the intracellular pool of MHC II mole-
cules from MIICs (Rescigno et al., 1997). The kinetics with
which MHC II and costimulatory molecules were expressed
at the plasma membrane were determined by FACS
 
®
 
 analysis
(Fig. 1 A). After a lag of 
 
 
 
1 h, the surface expression of MHC
II rapidly increased after LPS treatment, and half maximal ef-
fects were obtained between 2 and 6 h, in line with the notion
that MHC II is recruited from a preexisting intracellular pool.
2 d after addition of LPS, the amount of MHC II at the
plasma membrane was increased fivefold compared with im-
mature cells. In contrast to MHC II, surface expression of the
costimulatory molecule CD40 increased linearly with a lag of
at least 3 h after LPS stimulation, consistent with transcrip-
tional regulation. The expression of the costimulatory mole-
cules CD80 (B7.1, unpublished data) and CD86 (B7.2) also
increased with kinetics intermediate to those of MHC II and
CD40. To analyze the contribution of de novo synthesis on
the increase in cell surface expression of MHC II and B7.2,
cells were stimulated with LPS in the presence of cyclohexim-
ide, a drug that blocks protein synthesis. The increase in cell
surface expression of MHC II in response to LPS was not af-
fected by cycloheximide, whereas the upregulation of B7.2 on
the surface was inhibited strongly (Fig. 1 B). We conclude
that the increased surface expression of MHC II but not that
of B7.2 was due to its redistribution from an intracellular stor-
age site. Surprisingly, CLIP-associated MHC II appeared at 
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the plasma membrane with kinetics indistinguishable from to-
tal MHC II, indicating that peptide loading was not required
for MHC II transport to the surface (Fig. 1 A). Finally, we de-
termined the stability of MHC II heterodimers in SDS as a
measure for peptide loading (Fig. 1 C). In contrast to intact Ii
or CLIP-associated MHC II, peptide-loaded MHC II mole-
cules are stable usually in the presence of SDS at room tem-
perature and can be detected as a complex of 
 
 
 
 60 kD by
Western blot analysis (Davidson et al., 1991; Germain and
Hendrix, 1991). When immature D1 cells were lysed at room
temperature in SDS sample buffer, 
 
 
 
50% of the MHC II
 
 
 
-chain remained in a complex with the MHC II 
 
 
 
-chain.
When the temperature was elevated to 37, 60, or 100
 
 
 
C, in-
creasing amounts of MHC II became unstable, but surpris-
ingly a significant amount of the complex remained even at
100
 
 
 
C. In contrast, when D1 cells were treated with LPS for
2 d before lysis the majority of the MHC II complex was sta-
ble in the presence of SDS at room temperature but com-
pletely dissociated at 100
 
 
 
C. These data indicate that the
amount of MHC II that was loaded with peptide increased
significantly during D1 maturation. In addition, the heat sta-
ble complexes of MHC II present in immature cells were lost
upon maturation, possibly due to degradation or additional
peptide editing by DM (for review see Jensen et al., 1999).
 
LPS induces tubulation of MIICs
 
As a result of the massive transport of MHC II molecules
from MIICs to the cell surface within a short time period,
 
we anticipated to see this transport reflected in the mor-
phology of the endocytic compartments/MIICs upon stim-
ulation with LPS. First, we applied whole-mount EM
(Stoorvogel et al., 1996) to obtain an overall morphological
three-dimensional impression of the endocytic system (Figs.
2 and 3). This technique reveals the overall shape and char-
acteristics of endosomes and lysosomes. Immature and LPS-
stimulated D1 cells were allowed to endocytose HRP as a
fluid phase marker for 1 h at 37
 
 
 
C and were then incubated
at 0
 
 
 
C with diaminobenzidine
 
 
 
(DAB) in the presence of
H
 
2
 
O
 
2
 
. DAB diffuses through membranes and is rapidly po-
lymerized in HRP-containing compartments. Only endoso-
mal and lysosomal proteins are cross-linked to DAB poly-
mer by this procedure, allowing removal of nonlinked
cytosolic proteins after subsequent permeabilization of the
plasma membrane with saponin. Saponin-treated cells were
then fixed with aldehydes, immunolabeled with colloidal
gold, and studied as whole-mount preparations by trans-
mission EM. The most striking difference that we observed
between LPS-treated and nontreated cells was a shape
change of the endocytic compartments/MIICs. Immature
DCs were characterized by the presence of numerous elec-
tron-dense vacuolar MIICs, which localized predominantly
to the perinuclear area (Fig. 2 A). The nucleus and cytoskel-
etal elements can be seen as electron-dense structures also.
Fig. 2 B shows a maturing DC that was incubated for 1 h
with HRP after which LPS was added for 6 h. At this time,
the cells were in the process of actively redistributing MHC
Figure 1. LPS-induced expression of MHC II and costimulatory molecules at the plasma membrane. (A) D1 cells were cultured in 96-well 
plates and incubated for 0, 1, 3, 6, or 48 h with LPS. The surface expression of MHC II, CLIP-associated MHC II (MHC II/CLIP), CD40, and 
B7.2 was analyzed by FACS
®. (B) Cells were cultured as above for 0, 1, 2, 3, 4, 5, 6, and 7 h with LPS either in the presence or absence of 
cycloheximide. Surface expression of B7.2 and MHC II was analyzed by FACS
®. (C) Cells were lysed after 48 h of culture in the presence or 
absence of LPS in SDS sample buffer. Samples were incubated at room temperature, 37, 60, or 100 C and analyzed by Western blotting for 
MHC II  -chain. The Western blot shows monomeric MHC II  -chain and SDS stable MHC II. Upon stimulation with LPS, the amount of SDS 
stable MHC II/peptide complexes at room temperature strongly increased on expense of SDS unstable MHC II molecules. In contrast, the 
amount of SDS stable complexes at 100 C decreased after maturation. (D) Immature D1 cells secreted  7% of their  -hexosaminidase in a 
linear fashion during 18 h. The release increased only slightly after 4 and 8 h of LPS treatment but was unchanged at 18 h. 
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II to the cell surface (Fig. 1 A). Most notably, the vacuolar
MIICs were transformed into tubular MIICs, which ex-
tended towards the cell periphery (Fig. 2 B, arrows). A sim-
ilar morphology was obtained after a 3-h chase in the pres-
ence of LPS (unpublished data).
To characterize these compartments further, whole-
mount preparations of immature and LPS-treated D1 cells
were double immunolabeled using antibodies that are di-
rected against the cytoplasmic domains of relevant mem-
brane proteins. Both the vacuolar and tubular DAB-posi-
tive compartments labeled for MHC II, DM, LAMP-1
(Fig. 3, A–E) and Ii tail (unpublished data) thereby identi-
fying these structures as MIICs (Peters et al., 1991, 1995;
Nijman et al., 1995; Kleijmeer et al., 1997). The tubular
MIICs had a diameter 
 
 
 
200 nm (Fig. 3, B–E) and seemed
to form from the vacuoles (Fig. 3 B). Vesicles with a similar
diameter (Fig. 3, B–E, arrows) that were also labeled for
MHC II, DM, and LAMP-1 were often encountered close
to the tips of the tubules (Fig. 3 D). Since the cells were
pulse-chase labeled with HRP, the presence of DAB poly-
mer in the tubules and vesicles indicated that they were
formed from vacuolar MIICs. We propose that the free ves-
icles transport MHC II out of the tubular MIICs, probably
to the plasma membrane.
 
MHC II is recruited from the internal membranes 
of MIICs
 
Next, we studied whether the transformation of vacuolar
into tubular MIICs involved membrane rearrangements
within the MIICs by performing immuno-EM on cryosec-
tions. In immature cells, MHC II was primarily associated
with the 250–600 nm vacuolar multivesicular MIICs (Fig.
4, A and C), and only little was displayed at the plasma
membrane (Fig. 4 A). In contrast, after 48 h of LPS, MHC
II labeling was increased strongly at the plasma membrane,
whereas residual MIICs were almost devoid of MHC II (Fig.
4 B). The most striking difference between MIICs in imma-
ture (Fig. 4, A and C) and mature (Fig. 4 B) cells was the
disappearance of their internal membranes. After 3–6 h of
LPS treatment, tubular MIICs appeared either with a dense
content and only a few internal membranes or without al-
most any visual content (Fig. 4 D). The disappearance of in-
ternal membranes from MIICs and the coincident appear-
ance of tubules and vesicles (diameter 
 
 
 
200 nm) was
quantified by a morphometric analysis in which the surface
density of the internal membranes was determined after 0, 2,
5, or 24 h of LPS. Compared with the control, after 5 and
24 h of LPS the surface density of internal membranes de-
creased 2- and 4.5-fold, respectively (Fig. 5 A). Concomi-
tantly, the surface density of MIICs limiting membrane de-
creased with 
 
 
 
40% after 24 h. These figures are consistent
with transfer of membrane from the internal vesicles to the
limiting membrane of MIICs and with a net transfer of
membrane from MIICs to the plasma membrane. To inves-
tigate whether the decrease in internal membranes was ac-
companied by a redistribution of MHC II, we determined
the relative subcellular distribution of MHC II. In immature
cells, intracellular MHC II was associated almost exclusively
with MIICs, and only minor amounts were associated with
the biosynthetic pathway (Fig. 5 B). Within the MIICs,
 
 
 
80% was associated with the internal vesicles and the re-
mainder with the limiting membrane (Fig. 6 A). The pres-
ence of MHC II on internal membranes strongly decreased
upon LPS treatment with a corresponding increase at the
plasma membrane. The ER, Golgi, and undefined organelles
did not contribute to the increased plasma membrane-asso-
ciated pool of MHC II. Together with the notion that this
increase occurred independently of de novo synthesis of
MHC II (Fig. 1, A and B), these data indicate that MHC II
is redistributed from the internal vesicles of MVBs to the
plasma membrane.
Figure 2. LPS-induced remodeling of the endocytic system shown 
by whole-mount EM. For the inspection of endosomes and lyso-
somes (MIICs) in overview at the EM level, D1 cells were allowed to 
endocytose HRP as a fluid phase marker for 1 h (A) or were loaded 
for 1 h with HRP after which LPS was added for 6 h (B). Cells were 
chased for 10 min in the absence of HRP and then processed for 
whole-mount viewing of HRP-containing compartments. (A) 
Unstimulated cell with numerous vacuolar MIICs. (B) Stimulated 
cell with drastically remodeled long MIIC tubules extending into 
the dendrites of the cell (arrows). n, nucleus. Bar, 4  m. 
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LPS redistributed MHC II from the internal vesicles to 
the DM-containing limiting membrane of MIICs
 
Since MHC II together with the pool of internal membranes
was depleted from MIICs, we next investigated whether these
membranes could be redistributed to the limiting membrane
of MVBs from where they could find their way to the cell sur-
face. At 0 and 2 h of LPS treatment, only 20% of MHC II
was located on the limiting membrane of MIICs. However,
after 5 and 24 h of LPS treatment, we found 30 and 50%, re-
spectively, of MHC II on the limiting membrane (Fig. 6 A),
most likely as a result of the insertion of MHC II–enriched in-
ternal membrane. It should be noted that the extent of this re-
distribution is probably underestimated, since after 5 and 24 h
of LPS treatment a significant amount of MHC II had been
recruited already from the limiting membrane of MIICs to
the plasma membrane (Fig. 1 A). When we compared the rel-
ative distribution of MHC II with that of DM, striking differ-
ences were observed. In contrast to MHC II, in immature
cells DM was relatively enriched (70%) on the limiting mem-
brane of MIICs (Fig. 6 A and Fig. 7 A). The relative distribu-
tion of DM was not effected by LPS treatment. Since DM
plays an important role in MHC II peptide loading, we pre-
dicted that peptide loading of MHC II might be enhanced at
the limiting membrane due to the increased concentration of
DM at this domain. To test this hypothesis, we used BMDCs,
long term cultured bone marrow–derived DCs from B10.A
(5R) mice that express the YA
 
e
 
 epitope. This epitope is
formed by I-A
 
b
 
 associated with E
 
 
 
 (Dr
 
 
 
)52-68 peptide (Mur-
phy et al., 1989; Rudensky et al., 1991; Eastman et al., 1996).
This peptide originates from an endogenous protein, the I-E
 
 
 
chain, and loading of this peptide onto MHC II occurs in
MIICs and is dependent on DM (Kovats et al., 1998).
After 6 h of LPS treatment, MIICs in BMDCs abun-
dantly labeled for the YA
 
e
 
 epitope (Fig. 7 B) with 70% of
the label associated with the limiting membranes. These data
cannot be compared directly with those obtained for D1
cells. Nevertheless, they suggest that peptide loading of
MHC II is enhanced after its redistribution to the limiting
membrane of MIICs by the increased availability of DM.
Therefore, the reorganization of MVBs may contribute to
the regulation of MHC II peptide loading.
 
MHC II is not sorted from DM during its recruitment 
from MIICs
 
We next addressed the question of whether MHC II and
DM were sorted during the membrane reorganization of
MIICs. Incorporation of MHC II–rich/DM-poor internal
membranes into the MHC II–poor/DM-rich limiting mem-
Figure 3. MIICs in immature and 
maturing D1 cells. Cells were loaded 
with HRP for 1 h in the absence of LPS 
as in the legend to Fig. 2 A (A) or 1 h in 
the presence of HRP plus 6 h HRP   LPS 
(B and C) or pulsed for 1 h with HRP and 
chased for 3 h in the presence of LPS 
(D and E) and processed for whole-
mount EM. (A) Vacuolar MIICs in imma-
ture D1 cells labeled for MHC II (10 nm 
gold) and DM (15 nm gold). Tubular 
MIICs have formed after 3 (D and E) or
6 h (A and B) of LPS treatment. (B) Dou-
ble labeling for MHC II (10 nm gold) and 
DM (15 nm gold). A tubule seems to 
form out of the vacuole in the left 
bottom corner. (C) Tubular MIICs 
labeled for MHC II (10 nm gold) and 
LAMP-1 (15 nm gold), demonstrating the 
late endosomal/lysosomal character of 
these organelles. (D) Tubular MIICs and 
free vesicles (arrowheads) with diame-
ters ranging from 80 to 200 nm were 
double labeled for MHC II (10 nm gold) 
and DM (15 nm gold). Note the vesicle 
that seems to be formed at the tip of a 
tubule (thick arrow). (E) Tubular MIICs, 
showing DM (10 nm gold) and LAMP-1 
(15 nm gold). Note the cytoskeletal ele-
ments in which the MIICs are embedded. 
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brane was expected to result in changing densities of these
molecules in the limiting membrane of MIICs. To address
this point, we determined the labeling densities of MHC II
and DM in the internal and limiting membranes of MIICs
after 3 h of stimulation with LPS, a situation at which both
vacuolar MIICs and tubules/vesicles were encountered in
Figure 4. LPS-induced depletion of the 
MIICs internal membranes. Ultrathin 
cryosections of untreated D1 cells 
(A and C) or D1 cells treated with LPS for 
48 (B) or 3 h (D) were immunolabeled for 
MHC II with 10 nm gold particles. In A, 
MHC II is primarily present in vacuolar 
MIICs (stars) comprised of a limiting 
membrane surrounding internal vesicles 
and membranous sheets. Only a few 
gold particles are present at the plasma 
membrane (PM). In contrast, in the LPS-
treated D1 cell in B the plasma mem-
brane is labeled strongly for MHC II, 
whereas only little MHC II localizes to 
MIICs, which have few internal mem-
branes (stars). (C) Vacuolar MIICs (V) 
display many internal membrane vesi-
cles that are labeled for MHC II, whereas 
the limiting membrane is labeled 
scarcely. (D) MHC II–positive tubules (T) 
and vesicles (arrowheads) after 3 h
of stimulation with LPS. The dense 
vacuolar part is marked by a star. N, nu-
cleus. Bars: (A and B) 250 nm; (C and D) 
200 nm.
Figure 5. Morphometric analysis of 
MIIC membrane domains and subcellular 
distribution of MHC II. Random pictures 
(20 ) were taken of ultrathin cryosections 
of D1 cells incubated for 0, 2, 5, or 24 h 
with LPS. The sections were immuno-
labeled for MHC II. (A) Surface densities of 
internal and limiting membranes of MIICs. 
Significant differences were found for the 
surface density of internal vesicles after 5 
and 24 h. (B) The change in relative distri-
bution of MHC II gold particles over PM, 
MIICs, ER   Golgi complex, and others 
(n.d.   cytosol   mitochondria   
nucleus) was determined on random 
pictures (*p   0.05; **P   0.005). 
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the same cell. On the vacuolar MIICs, the labeling density
of MHC II on the limiting membrane was similar to that of
DM, whereas on tubules and vesicles the density of MHC II
was fivefold higher than that of DM (Fig. 6 C). It should be
noted that tubules are only recognized as such when they are
oriented in the plane of the section. The labeling densities of
MHC II and DM at the internal membranes were the same
for the two MIIC types (Fig. 6 D). At the limiting mem-
brane, the labeling density of DM was less at the T/Ve than
at the vacuoles as can be expected when this membrane is di-
luted with fusing internal membranes that are poor in DM.
Together, these data are consistent with a model in which
upon maturation internal membranes are recruited to the
limiting membrane (Fig. 8).
Figure 6. Labeling characteristics of 
MHC II and DM in MIICs. (A) Ultrathin 
cryosections of D1 cells incubated for 0, 
2, 5, or 24 h with LPS were labeled for 
MHC II or DM. The relative amount of 
labeling on the limiting membrane was 
determined and expressed as the 
percentage of total labeling on MIICs. 
Treatment with LPS induced a clear 
redistribution of MHC II towards the 
limiting membrane, whereas the distri-
bution of DM did not change. (B) The 
population of 200 DAB-containing MHC 
II and/or DM-labeled transport vesicles 
indicated in Table I were grouped 
according to their MHC II and DM 
content. Each bar represents the number 
of vesicles having a certain labeling 
characteristic. Only a single population 
of vesicles, containing both MHC II and 
DM, was observed. (C) The labeling 
densities of MHC II and DM on limiting 
and internal membranes of MIICs were 
measured in electron micrographs of 
cells treated for 3 h with LPS. Labeling 
densities on the limiting membranes of V 
and T/Ve are expressed as the ratios of gold particles over membrane surface areas (as described in Materials and methods). The labeling 
density of MHC II on the limiting membrane of V is less than two times that of T/Ve. (D) Labeling densities of MHC II and DM on internal 
membranes do not alter after LPS treatment (*p   0.05; **P   0.005).
Figure 7. Localization of DM and YAe on 
the limiting membrane of MIIC. (A) Double 
immunolabeling of MIICs (stars) in immature 
D1 cells, showing DM (15 nm) primarily on the 
limiting membrane (arrowheads) of MIICs and 
most of the MHC II (10 nm) on internal mem-
branes. N, nucleus; PM, plasma membrane. 
(B) Immunolabeling showing YAe on the 
limiting membrane of MIICs (stars) in BMDCs. 
Bars, 200 nm. 
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To determine whether MHC II is selectively incorporated
into the vesicles that derive from the tips of the tubular MIICs,
we performed a quantitative analysis of the distribution of DM
and MHC II on whole-mount preparations. We examined the
relative labeling densities of MHC II and DM on the vesicles
and on the tubular MIICs and their tips, the putative vesicle
formation sites (Table I). A tip was defined as a segment at the
end of each tubule with a length equal to its diameter. On the
tubules, the labeling density of MHC II was 3.2-fold higher
than that of DM. On buds and vesicles, similar ratios, 3.3 and
3.8, respectively, were observed, suggesting that MHC II mol-
ecules are not sorted away from DM during vesicle formation.
As illustrated in Fig. 6 B, we did not observe transport vesicles
that are exclusively enriched in MHC II or DM. A single pop-
ulation of vesicles containing both MHC II and DM was ob-
served. This predicts that DM is transported together with
MHC II from tubular MIICs to the plasma membrane by a
default process. We propose that the MHC II/DM-positive
vesicles and not entire tubules mediate transport to the cell sur-
face. In the event of fusion of MIIC tubules with the plasma
membrane, their entire soluble content would be quantita-
tively transferred to the extracellular milieu. However, when
we measured the release of the lysosomal enzyme 
 
 
 
-hex-
osaminidase in the medium, LPS treatment only slightly in-
creased the secretion of the enzyme in the medium (Fig. 1 D).
 
Discussion
 
In antigen-presenting cells, the main type of MIIC in which
peptide loading of MHC II occurs is constituted of MVBs
(for review see Geuze, 1998). Here, we present data that ex-
plain how immature DCs can efficiently retain MHC II
molecules in their MIICs and recruit them from these stores
to the cell surface during maturation. In immature D1 cells,
 
 
 
65% of MHC II was contained by their MIICs, of which
80% was associated with the internal vesicles. In contrast,
DM was associated predominantly with the limiting mem-
brane of the MIIC (70%). This differential distribution
may be due to a selective retention of DM at the limiting
membrane and by active incorporation of MHC II into the
internal vesicles. The latter possibility seems to be the major
determinant, since the density of MHC II is much higher at
the internal vesicles than at the limiting membrane (Fig. 6,
B–D). Already after a few hours of LPS treatment, long tu-
bules egressed from the MVBs, reaching out into the pe-
riphery of the cell. Both the vacuolar and tubular MIICs
showed the characteristics of late endosomal/lysosomal
compartments as demonstrated by the presence of LAMP-1,
DM, and HRP uptake kinetics. The tubulating MIICs were
reminiscent of tubulo/vesicular lysosomes in macrophages
that are formed after stimulation with phorbol esters (Swan-
son et al., 1987). In the whole-mount preparations, the tu-
bular nature of MIICs appeared more prominent than in
sections of aldehyde-fixed cells. Apart from the inherent
limitation of showing tubules in sections, this was possibly
also due to the fixation with aldehydes. Aldehyde fixation
results in the fractionation of long tubular MIICs as re-
ported for tubular lysosomes in macrophages (Robinson
and Karnovsky, 1991). In the whole-mount procedure,
MIICs were fixed by DAB polymer, and this prevented their
fractionation as suggested by cryosections of HRP-loaded
cells that were aldehyde fixed after DAB treatment (unpub-
lished data). MIICs must recruit considerable amounts of
additional limiting membrane to accomplish their tubula-
tion. Our morphometric analysis indicates that this mem-
brane most likely originates from the internal membrane
vesicles of the MVBs. Fusion of internal vesicles with the
limiting membrane might even drive the tubulation of these
organelles. To our knowledge, this is the first demonstration
that internal membrane vesicles of MVBs serve as a storage
compartment from which membrane proteins can be re-
cruited on demand.
Figure 8. Tubulation of multivesicular MIICs during DC maturation. 
Multivesicular MIICs in DCs undergo a dramatic shape change from 
vacuolar to tubular upon stimulation, most likely by fusion of the 
MIIC internal membrane vesicles with the limiting membrane. This 
implies that MHC II–rich internal membranes stored in the lumen of 
the vacuolar MIIC relocate to the limiting membrane of the tubular 
MIICs, allowing egress of MHC II from these tubules to the plasma 
membrane. The final transport step to the cell surface is probably 
mediated by transport vesicles, which bud from the tubular MIICs 
and nonselectively incorporate MHC II. As a consequence of MHC 
II translocation to the DM-rich limiting membrane, contact between 
DM and MHC II is increased, which may facilitate peptide loading 
and editing during maturation.
 
Table I. 
 
DM is not segregated from MHC II during vesicle 
formation from MIIC tubules
Tubules Buds Vesicles
 
MHC II gold particles 2785 1683 2069
DM gold particles 885 513 545
Ratio MHC II/DM 3.2 3.3 3.8
Whole-mount preparations of LPS-stimulated D1 cells were double
immunolabeled for MHC II and DM as in Fig. 3 D. The samples were
scanned randomly for labeled tubular 100–200 nm MIICs and 100–150 nm
vesicles. The tubules were divided into “buds,” defined as the distal end of
a tubule with a length equal to its diameter, and the remainder of the tubule.
The number of gold particles representing MHC II or DM on 200 vesicles
and 94 tubules and 170 buds were counted, and the ratio of the two
markers was calculated for each structure. 
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The transport intermediates from the tubular MIICs to the
plasma membrane are most likely the 80–200 nm vesicles.
Several arguments favor this idea. First, their diameter is simi-
lar to that of the MIIC tubules, and they are often encoun-
tered proximate to the tips of these tubules. Second, endocy-
tosed HRP is found in these vesicles even after chase times of
6 h, indicating that they originate from compartments that are
positioned late in the endocytic tract. Third, they are, like
MIICs, labeled for both MHC II and DM, demonstrating their
relationship with MIICs. It is unlikely that fusion of entire
MIICs with the plasma membrane provides a major pathway
for MHC II traffic because the release of 
 
 
 
-hexosaminidase
was increased only slightly upon stimulation with LPS. How-
ever, fusion of entire MIICs with the plasma membrane of D1
cells does occur to some extent as illustrated by the release of
exosomes (Thery et al., 1999; unpublished data). D1 cells that
were stimulated for 24 or 40 h with LPS released exosomes less
efficiently than immature cells (Thery et al., 1999). This ob-
servation may be explained by our finding that MIICs in the
mature cells are depleted from internal vesicles. Thus, exosome
secretion can be expected to go down irrespective of the fre-
quency of MIIC fusion with the plasma membrane.
Based on our observation that in maturing D1 cells MHC
II is not selectively concentrated at the tips of tubular MIICs
nor on the putative transport vesicles, we conclude that sort-
ing information is not required for MHC II to egress from
MIICs. This is consistent with the observation that in a mu-
rine B lymphoma cell line, transport of MHC II to the cell
surface occurs independently of the cytoplasmic domains of
the 
 
 
 
- and 
 
 
 
-chains (Thery et al., 1998) and with the lack of
recruitment of peptide-loaded MHC II molecules by clath-
rin coats present on MIICs (Ramm et al., 2000). That a ve-
sicular intermediate similar to the CIIV described in B cells
(Amigorena et al., 1994; Pierre et al., 1997b) is involved in
transport to the cell surface has been suggested also by Tur-
ley et al. (2000) in a study on developing bone marrow–
derived DCs. The CIIV is thought to move from MIICs to
the plasma membrane, carrying MHC I, MHC II, and B7
costimulatory molecules. Possibly, CIIVs are similar to the
putative transport vesicles or tubular structures in our study.
However, one discrepancy is that CIIVs lack DM as mea-
sured by immunofluorescence, but this may be due to the
higher detection efficiency of DM by whole-mount EM in
our study. Since the transport vesicles in our study do con-
tain DM, one may expect an enhanced surface expression of
DM upon stimulation. Although DM was observed occa-
sionally at the plasma membrane, we were unable to demon-
strate increased DM expression upon stimulation. However,
others have shown that functional DM is present at the cell
surface of B cells and DCs. The reason why we did not de-
tect increased levels of DM at the plasma membrane may be
due to rapid endocytosis of surface-targeted DM (Lindstedt
et al., 1995; Riese et al., 1996), resulting in regurgitation to
MIICs and low surface levels at steady state. Thus, sorting
between DM and MHC II in maturing DCs may occur at
the plasma membrane rather than at MIICs.
During maturation, DCs upregulate MHC II peptide
loading and transport to the cell surface (Pierre and Mell-
man, 1998; Inaba et al., 2000). In DCs from cathepsin
S–deficient mice (Driessen et al., 1999) and in cells that
were incubated in the presence of an inhibitor of cathepsin S
(Pierre and Mellman, 1998), surface expression of MHC II
was delayed severely. Since cathepsin S is required for the fi-
nal processing of Ii (Riese et al., 1996; Villadangos et al.,
2000), it has been proposed based on these data that the cy-
toplasmic domain of Ii might prevent MHC II from escap-
ing MIICs. However, we observed that upon D1 stimula-
tion, MHC II is recruited to the cell surface with the same
kinetics as CLIP-associated MHC II, indicating that the re-
cruitment process lacks specificity and that peptide loading
is not required. Probably, Ii-associated MHC II is endocy-
tosed rapidly upon reaching the plasma membrane and shut-
tled back to MIICs. Alternatively, Ii might be required to ac-
tively target newly synthesized MHC II to the internal
vesicles of MIICs in immature DCs.
Our results show that DCs employ the internal mem-
branes of their multivesicular MIICs to temporarily store
large amounts of MHC II molecules and that they execute a
radical reorganization of their MIICs to mediate rapid trans-
fer MHC II to the cell surface upon activation. Maturation
of D1 cells also involved increased peptide loading on MHC
II and possibly editing of peptides that were associated al-
ready with MHC II before maturation (Fig. 1 C). Sorting of
MHC II molecules into the internal vesicles of MVBs in im-
mature cells by itself provides a physical restraint for egress
to the cell surface. In addition, the relatively low amount of
DM associated with the internal membranes may prevent
peptide loading of a large pool of MHC II molecules in im-
mature DCs. Fusion of MHC II–containing membranes
with the DM-rich limiting domain of the MIIC brings the
molecules together and will enhance the efficiency of pep-
tide loading and editing by DM.
Others already concluded that peptide loading is not the
only regulatory process for MHC II transport to the cell sur-
face in maturing DCs (Pierre and Mellman, 1998; Inaba et
al., 2000). In our study, cycloheximide did not interfere
with the LPS-induced increase in the expression of MHC II
at the plasma membrane, indicating that newly synthesized
MHC II molecules did not contribute significantly to this
process. This is consistent with the observation that stimu-
lated D1 cells did not show a high increase in their synthesis
of MHC II (Rescigno et al., 1998) and that the relative con-
tribution of MHC II in the ER and Golgi complex did not
change during LPS treatment (Fig. 5 A).
The regulated recruitment of internal vesicles of MVBs to
their limiting membrane is an entirely new concept. For
DCs, this process allows for the timed recruitment of pre-
synthesized MHC II to the plasma membrane and possibly
has a regulatory function in peptide loading. Similar mecha-
nisms may be employed by other cells to regulate the surface
expression of distinct sets of membrane proteins.
 
Materials and methods
 
Materials
 
D1 cells are long term cultured growth factor–dependent immature splenic
DCs derived from C57BL/6 (H-2
 
b
 
) mice (Winzler et al., 1997). BMDCs
were generated from bone marrow of B10.A (5R) mice. Cells were grown
in IMDM containing 10% heat-inactivated FCS (GIBCO BRL), 100 IU/ml
penicillin, 100 
 
 
 
m/ml streptomycin, 2 mM 
 
L
 
-glutamine, 50 
 
 
 
M 2-mercap-
toethanol (all from Sigma-Aldrich), and 35% conditioned medium from R1 
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cells (Winzler et al., 1997). BMDCs were grown for 15–20 d in DC me-
dium, and homogeneity of the DC culture was evaluated by cytofluorime-
try (unpublished data).
LPS (
 
Escherichia coli
 
, serotype 026:B6) was obtained from Sigma-
Aldrich. Cycloheximide (Sigma-Aldrich) was used at 10 
 
 
 
g/ml. Rabbit
polyclonal antibody directed against the cytoplasmic domains of DM
(Barois et al., 1998), MHC II 
 
 
 
-chain, and Ii (Barois et al., 1997) were ob-
tained from Dr. Barois (University of Oslo, Oslo, Norway). Monoclonal rat
anti–mouse MHC II (M5/114 and PE-coupled M5/114 [Bhattacharya et al.,
1981]) and FITC-coupled CD86/B7.2 antibody (GL1) was purchased from
PharMingen. PE-coupled CD40 antibody (3/23) was obtained from Sero-
tec. Mouse monoclonal YA
 
e
 
 is directed against I-A
 
b
 
 associated with E 
(Dr )52-68 peptide (Murphy et al., 1989; Rudensky et al., 1991; Eastman
et al., 1996) and mouse monoclonal 15G4 against I-A
b/CLIP. Rat mono-
clonal K553 against DM was a gift from Dr. L. Karlsson, (Scripps Research
Institute, La Jolla, CA). Rabbit anti–rat IgG was obtained from Dako.
Western blot analysis and  -hexosaminidase measurements
To determine the stability of MHC II in SDS, cells were cultured for 48 h in
the presence or absence of 10  g/ml LPS and lysed in SDS sample buffer.
Samples of the lysates were incubated either at room temperature for 10
min at 37 C, 5 min at 60 C, or 5 min at 100 C and analyzed by Western
blotting according to standard procedures using polyclonal anti– -MHC II
(see above) and ECL detection.
To determine the secretion of  -hexosaminidase, cells were cultured
during the last 18, 8, 4, or 2 h in fresh medium in the presence or absence
of 10  g/ml LPS. The media were harvested simultaneously and supple-
mented with 1% Triton X-100. The cells were lysed in medium containing
1% Triton X-100. Media and cell lysates were centrifuged for 1 min at
10,000 g, and samples of the supernatants were analyzed for  -hexosamini-
dase activity as described (Green et al., 1987). Release of  -hexosamini-
dase was expressed as the activity in the culture medium as a percentage of
the total activity, released and intracellular, from the same culture dish.
Whole-mount immunoelectron microscopy
Whole-mount immunocytochemistry was performed principally as de-
scribed (Stoorvogel et al., 1996). In short, cells were grown on gold grids
carrying a formvar film and processed 3 d after seeding. Cells were incu-
bated for 1 h in medium containing dialyzed HRP (type II, 5 mg/ml;
Sigma-Aldrich) and chased either in the presence or absence of LPS for
the time indicated. Cells were washed rapidly at 0 C and incubated in
DAB-containing buffer. After HRP-catalyzed filling of endocytic compart-
ments with DAB polymer, soluble cytosolic proteins were removed by
permeabilizing the cells with saponin. Permeabilized cells were then
fixed with 2% paraformaldehyde and 0.2% glutaraldehyde in 0.1 M phos-
phate buffer, pH 7.4. Immunolabeling was performed at room tempera-
ture. In double-labeling experiments, cross labeling was excluded in con-
trol samples in which the primary antibody was omitted during the
second labeling step. After labeling, cells were dehydrated in ethanol,
critical point dried, and coated with a carbon film. For quantitative analy-
sis, gold particles were counted on randomly selected vesicles, tubules, or
indicated sections of tubules.
Immunoelectron microscopy on cryosections
Cells were detached from the culture plates during a short incubation in
PBS/2 mM EDTA. Detached cells were pooled with nonadherent cells,
washed with FCS-free medium by centrifugation, and fixed in 2% parafor-
maldehyde and 0.2% glutaraldehyde for 2 h. The fixative was removed
and free aldehydes quenched at room temperature with 50 mM glycine in
PBS. The cells were embedded in 10% gelatin and prepared for ultrathin
cryosectioning and immunogold labeling (Raposo et al., 1997). Ultrathin
cryosections were single immunolabeled with 10 nm protein A gold parti-
cles or double immunolabeled with 10 and 15 nm gold particles. For the
overall distribution of MHC II and morphometric analysis, 2   10 random
pictures were taken at 20  for each condition. The pictures were encoded
and analyzed blindly by two independent individuals (2   5 pictures for
each per condition) for MHC II distribution and surface densities. Surface
densities of internal and limiting membranes related to the cell volume
were determined using a square lattice system, according to the method of
Weibel (1979). The percentage of MHC II and DM labeling on the limiting
membranes of MIICs was determined in the microscope on single-labeled
grids by counting the distribution of 1,000 and 500 gold particles on MIICs
for each condition. To determine labeling densities of MHC II and DM
vacuolar and tubular/vesicular, MIICs were photographed at a 30  magni-
fication. Only those gold particles that were within 20 nm of a membrane
were counted. Labeling densities of MHC II and DM represent the number
of gold particles per membrane surface area.
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